Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/RBM22_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/RBM22_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/RBM22_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Skin | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Skin/RBM22_pca_on_diff_genes.png) | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/RBM22_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1903829210 | Thyroid | ATC | positive regulation of cellular protein localization | 167/6293 | 276/18723 | 3.32e-20 | 5.38e-18 | 167 |
GO:003238825 | Thyroid | ATC | positive regulation of intracellular transport | 131/6293 | 202/18723 | 8.20e-20 | 1.24e-17 | 131 |
GO:009031624 | Thyroid | ATC | positive regulation of intracellular protein transport | 107/6293 | 160/18723 | 6.82e-18 | 7.84e-16 | 107 |
GO:004348435 | Thyroid | ATC | regulation of RNA splicing | 100/6293 | 148/18723 | 2.75e-17 | 2.72e-15 | 100 |
GO:190495128 | Thyroid | ATC | positive regulation of establishment of protein localization | 177/6293 | 319/18723 | 5.43e-16 | 4.29e-14 | 177 |
GO:005116833 | Thyroid | ATC | nuclear export | 100/6293 | 154/18723 | 1.63e-15 | 1.20e-13 | 100 |
GO:0046822112 | Thyroid | ATC | regulation of nucleocytoplasmic transport | 75/6293 | 106/18723 | 5.49e-15 | 3.62e-13 | 75 |
GO:005122234 | Thyroid | ATC | positive regulation of protein transport | 165/6293 | 303/18723 | 4.94e-14 | 2.69e-12 | 165 |
GO:190018023 | Thyroid | ATC | regulation of protein localization to nucleus | 87/6293 | 136/18723 | 3.94e-13 | 1.79e-11 | 87 |
GO:190018222 | Thyroid | ATC | positive regulation of protein localization to nucleus | 60/6293 | 87/18723 | 1.63e-11 | 5.88e-10 | 60 |
GO:0046824110 | Thyroid | ATC | positive regulation of nucleocytoplasmic transport | 45/6293 | 62/18723 | 3.93e-10 | 1.08e-08 | 45 |
GO:001703822 | Thyroid | ATC | protein import | 110/6293 | 206/18723 | 3.49e-09 | 8.09e-08 | 110 |
GO:000661132 | Thyroid | ATC | protein export from nucleus | 41/6293 | 57/18723 | 3.70e-09 | 8.52e-08 | 41 |
GO:004682533 | Thyroid | ATC | regulation of protein export from nucleus | 25/6293 | 30/18723 | 2.87e-08 | 5.44e-07 | 25 |
GO:005117018 | Thyroid | ATC | import into nucleus | 86/6293 | 159/18723 | 8.02e-08 | 1.40e-06 | 86 |
GO:000660617 | Thyroid | ATC | protein import into nucleus | 83/6293 | 155/18723 | 2.38e-07 | 3.70e-06 | 83 |
GO:190459119 | Thyroid | ATC | positive regulation of protein import | 31/6293 | 43/18723 | 2.80e-07 | 4.25e-06 | 31 |
GO:190458918 | Thyroid | ATC | regulation of protein import | 41/6293 | 63/18723 | 3.19e-07 | 4.76e-06 | 41 |
GO:004230718 | Thyroid | ATC | positive regulation of protein import into nucleus | 29/6293 | 41/18723 | 1.30e-06 | 1.66e-05 | 29 |
GO:004230617 | Thyroid | ATC | regulation of protein import into nucleus | 38/6293 | 60/18723 | 2.34e-06 | 2.76e-05 | 38 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RBM22 | SNV | Missense_Mutation | | c.616A>G | p.Asn206Asp | p.N206D | Q9NW64 | protein_coding | deleterious(0.04) | benign(0.038) | TCGA-D8-A1XK-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine+cyclophosphamide | SD |
RBM22 | insertion | Nonsense_Mutation | novel | c.384_385insTGGTATTAGGTCTATTTTGGTAATTATATTTTG | p.Ser128_Asp129insTrpTyrTerValTyrPheGlyAsnTyrIleLeu | p.S128_D129insWY*VYFGNYIL | Q9NW64 | protein_coding | | | TCGA-A8-A097-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | tamoxiphen | SD |
RBM22 | insertion | Frame_Shift_Ins | novel | c.369_370insTTTCATAGTTCTAAGACAT | p.Glu124PhefsTer7 | p.E124Ffs*7 | Q9NW64 | protein_coding | | | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RBM22 | deletion | Frame_Shift_Del | novel | c.696delN | p.Thr233HisfsTer7 | p.T233Hfs*7 | Q9NW64 | protein_coding | | | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
RBM22 | SNV | Missense_Mutation | novel | c.836C>T | p.Ala279Val | p.A279V | Q9NW64 | protein_coding | deleterious(0.02) | possibly_damaging(0.734) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
RBM22 | SNV | Missense_Mutation | rs755478465 | c.191N>A | p.Arg64His | p.R64H | Q9NW64 | protein_coding | tolerated(0.11) | probably_damaging(0.999) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
RBM22 | SNV | Missense_Mutation | | c.959A>G | p.Asp320Gly | p.D320G | Q9NW64 | protein_coding | tolerated(0.17) | benign(0.031) | TCGA-AA-3492-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RBM22 | SNV | Missense_Mutation | | c.602N>A | p.Arg201His | p.R201H | Q9NW64 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
RBM22 | SNV | Missense_Mutation | | c.125G>T | p.Gly42Val | p.G42V | Q9NW64 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AD-6895-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
RBM22 | SNV | Missense_Mutation | | c.391N>G | p.Thr131Ala | p.T131A | Q9NW64 | protein_coding | tolerated(0.33) | benign(0.017) | TCGA-AD-6964-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folfox | PD |